Literature DB >> 15561906

Genetic disruption of Kir6.2, the pore-forming subunit of ATP-sensitive K+ channel, predisposes to catecholamine-induced ventricular dysrhythmia.

Xiao-Ke Liu1, Satsuki Yamada, Garvan C Kane, Alexey E Alekseev, Denice M Hodgson, Fearghas O'Cochlain, Arshad Jahangir, Takashi Miki, Susumu Seino, Andre Terzic.   

Abstract

Metabolic-sensing ATP-sensitive K+ channels (KATP channels) adjust membrane excitability to match cellular energetic demand. In the heart, KATP channel activity has been linked to homeostatic shortening of the action potential under stress, yet the requirement of channel function in securing cardiac electrical stability is only partially understood. Here, upon catecholamine challenge, disruption of KATP channels, by genetic deletion of the pore-forming Kir6.2 subunit, produced defective cardiac action potential shortening, predisposing the myocardium to early afterdepolarizations. This deficit in repolarization reserve, demonstrated in Kir6.2-knockout hearts, translated into a high risk for induction of triggered activity and ventricular dysrhythmia. Thus, intact KATP channel function is mandatory for adequate repolarization under sympathetic stress providing electrical tolerance against triggered arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561906     DOI: 10.2337/diabetes.53.suppl_3.s165

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  35 in total

1.  K(ATP) channels process nucleotide signals in muscle thermogenic response.

Authors:  Santiago Reyes; Sungjo Park; Andre Terzic; Alexey E Alekseev
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

2.  Reduction in number of sarcolemmal KATP channels slows cardiac action potential duration shortening under hypoxia.

Authors:  Zhiyong Zhu; Colin M-L Burnett; Gennadiy Maksymov; Elizabeth Stepniak; Ana Sierra; Ekaterina Subbotina; Mark E Anderson; William A Coetzee; Denice M Hodgson-Zingman; Leonid V Zingman
Journal:  Biochem Biophys Res Commun       Date:  2011-11-03       Impact factor: 3.575

Review 3.  Muscle KATP channels: recent insights to energy sensing and myoprotection.

Authors:  Thomas P Flagg; Decha Enkvetchakul; Joseph C Koster; Colin G Nichols
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

Review 4.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 5.  Cardiac KATP channels in health and disease.

Authors:  Garvan C Kane; Xiao-Ke Liu; Satsuki Yamada; Timothy M Olson; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-04-25       Impact factor: 5.000

Review 6.  ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart.

Authors:  Alexey E Alekseev; Denice M Hodgson; Amy B Karger; Sungjo Park; Leonid V Zingman; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-04-14       Impact factor: 5.000

Review 7.  K(ATP) channel therapeutics at the bedside.

Authors:  A Jahangir; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

8.  Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms.

Authors:  Tong Lu; Dan Ye; Xiaoli Wang; John M Seubert; Joan P Graves; J Alyce Bradbury; Darryl C Zeldin; Hon-Chi Lee
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

Review 9.  Volatile anesthetic-induced cardiac preconditioning.

Authors:  Anna Stadnicka; Jasna Marinovic; Marko Ljubkovic; Martin W Bienengraeber; Zeljko J Bosnjak
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

10.  Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Authors:  Satsuki Yamada; Timothy J Nelson; Ruben J Crespo-Diaz; Carmen Perez-Terzic; Xiao-Ke Liu; Takashi Miki; Susumu Seino; Atta Behfar; Andre Terzic
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.